Abstract
Primary Epstein-Barr Virus (EBV) infection begins in the oropharynx where the virus establishes persistent infection of epithelial cells through continued cycles of infection, virus replication, cell death, virus release and infection of new cells. Early in primary infection, virus spreads from epithelial cells to subepithelial B lymphocytes. Infected B lymphocytes are largely non-permissive for virus replication. EBV establishes latent infection in B lymphocytes and transforms these cells so that they can secrete immunoglobulin and proliferate indefinitely in vitro. In immune deficient humans, EBV infected lymphocytes can also proliferate into malignant tumors. In latently infected B lymphocytes, EBV characteristically expresses a restricted set of virus genes which are presumed to i) maintain latent virus genome persistence, ii) cause the B lymphocyte growth transformation associated with latent viral infection and iii) represent targets for the immune response which is responsible for the prevention of outgrowth of latently infected B lymphocytes in humans.KeywordsBurkitt Lymphoma CellRodent FibroblastLatent Infection Membrane ProteinFollow Gene TransferChloramphenicol Acetyl Transferase Reporter GeneThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
